FDA-Drug2026-07-29Class IICHEMICAL
Major Pharmaceuticals levothyroxine sodium tablets recalled for subpotency
LABEL MIX UPNationwide distribution
Major Pharmaceuticals levothyroxine tablets recalled for subpotency
Major Pharmaceuticals is recalling one lot of Levothyroxine Sodium Tablets, USP, 25 mcg due to subpotency — meaning the tablets contain less active ingredient than labeled. This affects Lot N02212 with an expiration date of 07/2026. Patients taking subpotent levothyroxine may not receive the full intended dose of this thyroid hormone replacement medication.
- Check if you have Levothyroxine Sodium Tablets, USP, 25 mcg (NDC 0904-6949-61) with Lot N02212.
- Contact your pharmacist or doctor if you have this lot — do not stop taking the medication without guidance.
- Your doctor may need to adjust your dose or switch you to a replacement supply.
- Report any adverse effects to your doctor or the FDA MedWatch program.
Hazard
Subpotent Drug
Sold states
Nationwide in the USA.
Affected count
N/A
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6949-61
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0700-2026More Major Pharmaceuticals recalls
- FDA-Drug2026-07-29Major Pharmaceuticals Levothyroxine Sodium 75 mcg tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine sodium 150 mcg tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals Levothyroxine Sodium Tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine 75 mcg tablets recalled for subpotent drug
- FDA-Drug2026-07-29Major Pharmaceuticals Levothyroxine Sodium 125 mcg tablets recalled for subpotency
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief